CRSP RSI Chart
Last 7 days
9.9%
Last 30 days
1.2%
Last 90 days
-31.6%
Trailing 12 Months
-11.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 697.5M | 588.7M | 480.0M | 371.2M |
2022 | 806.2M | 0 | 0 | 0 |
2021 | 646.9M | 736.3M | 825.6M | 915.0M |
2020 | 0 | 378.9M | 468.3M | 557.6M |
2019 | 2.1M | 97.9M | 193.8M | 289.6M |
2018 | 31.5M | 22.1M | 12.6M | 3.1M |
2017 | 7.4M | 10.2M | 11.0M | 41.0M |
2016 | 1.2M | 2.1M | 3.1M | 5.2M |
2015 | 0 | 0 | 0 | 247.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 15, 2024 | kulkarni samarth | acquired | 374,408 | 19.12 | 19,582 | chief executive officer |
Apr 15, 2024 | kulkarni samarth | sold | -1,173,230 | 59.9138 | -19,582 | chief executive officer |
Mar 15, 2024 | kulkarni samarth | acquired | 764,800 | 19.12 | 40,000 | chief executive officer |
Mar 15, 2024 | kulkarni samarth | sold | -2,899,260 | 72.4814 | -40,000 | chief executive officer |
Mar 15, 2024 | prasad raju | sold | -256,160 | 72.69 | -3,524 | chief financial officer |
Mar 14, 2024 | prasad raju | acquired | - | - | 10,000 | chief financial officer |
Mar 12, 2024 | kulkarni samarth | sold | -341,159 | 74.44 | -4,583 | chief executive officer |
Mar 12, 2024 | kasinger james r. | sold | -85,308 | 74.44 | -1,146 | general counsel and secretary |
Mar 11, 2024 | kulkarni samarth | acquired | - | - | 9,000 | chief executive officer |
Mar 11, 2024 | kulkarni samarth | sold | -767,104 | 78.26 | -9,802 | chief executive officer |
Which funds bought or sold CRSP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Ancora Advisors LLC | added | 21.81 | 60,873 | 247,421 | 0.01% |
May 16, 2024 | B. Riley Wealth Advisors, Inc. | added | 0.27 | -286,483 | 763,006 | 0.02% |
May 16, 2024 | Global Financial Private Client, LLC | unchanged | - | 128 | 1,568 | -% |
May 16, 2024 | Arete Wealth Advisors, LLC | reduced | -1.04 | 53,389 | 742,740 | 0.07% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 1.06 | 421,975 | 4,628,130 | 0.01% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -63.14 | -17,802,600 | 11,932,900 | -% |
May 16, 2024 | WealthPlan Investment Management, LLC | reduced | -2.92 | 34,505 | 639,409 | 0.10% |
May 15, 2024 | ALGERT GLOBAL LLC | new | - | 580,000 | 580,000 | 0.02% |
May 15, 2024 | CAPITAL FUND MANAGEMENT S.A. | reduced | -23.15 | -746,259 | 3,824,730 | 0.01% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 29.74 | 88,243 | 302,085 | 0.01% |
Unveiling CRISPR Therapeutics AG's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to CRISPR Therapeutics AG)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
CRISPR Therapeutics AG News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | -100.0% | - | 201,206,000 | - | 70,000,000 | 100,000,000 | 56,449,500 | 12,899,000 | 824,000 | 900,701,000 | 735,964,000 | 571,227,000 | 406,490,000 | 241,753,000 | 77,016,000 | 211,928,000 | 106,128,000 | 328,000 | 115,000 | 563,000 | 1,088,000 | 16,706,500 |
Operating Expenses | 7.2% | 141,091,000 | 131,623,000 | 132,411,000 | 165,223,000 | 164,487,000 | 176,912,000 | 158,597,000 | 129,673,000 | 138,083,000 | 115,082,000 | 108,131,000 | 92,547,000 | 80,733,000 | 66,033,000 | 72,765,000 | 55,301,000 | 48,751,000 | 45,343,000 | 49,995,000 | 38,374,000 | - |
S&GA Expenses | -100.0% | - | 16,479,000 | 18,291,000 | 19,032,000 | 22,360,000 | 28,021,000 | 23,168,000 | 23,709,000 | 28,806,000 | 24,517,000 | 23,305,000 | 21,539,000 | 21,353,000 | 17,272,000 | 15,519,000 | 15,768,000 | 14,929,000 | 16,542,000 | 10,175,000 | 12,741,000 | 8,836,000 |
R&D Expenses | -19.9% | 76,172,000 | 95,144,000 | 90,698,000 | 101,555,000 | 99,935,000 | 118,245,000 | 103,605,000 | 83,500,000 | 82,332,000 | 70,620,000 | 36,801,000 | 71,008,000 | 59,380,000 | 48,761,000 | 57,246,000 | 39,533,000 | 33,822,000 | 28,801,000 | 39,820,000 | 25,633,000 | - |
EBITDA Margin | -49.2% | -0.53 | -0.35 | -0.71 | -0.68 | -0.72 | 0.42 | 0.43 | 0.52 | 0.63 | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | 215.3% | 700,000 | 222,000 | 412,000 | 900,000 | 1,320,000 | 3,600,000 | -2,232,500 | -595,000 | 4,100,000 | 600,000 | -169,000 | 200,000 | 400,000 | 26,000 | 274,000 | 85,000 | 85,000 | 234,000 | 137,000 | 96,000 | - |
Earnings Before Taxes | -229.3% | -115,867,000 | 89,580,000 | -111,740,000 | -76,817,000 | -51,745,000 | -175,609,000 | -143,501,000 | -127,748,000 | 763,368,000 | -112,588,000 | -107,186,000 | -92,239,000 | -79,277,000 | 30,546,000 | 138,697,000 | -53,614,000 | -48,323,000 | -47,356,000 | -50,574,000 | -38,284,000 | - |
EBT Margin | -42.5% | -0.58 | -0.41 | -0.75 | -0.72 | -0.76 | 0.39 | 0.41 | 0.50 | 0.61 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -230.5% | -116,591,000 | 89,347,000 | -112,152,000 | -77,740,000 | -53,065,000 | -179,217,000 | -141,248,000 | -127,153,000 | 759,225,000 | -113,163,000 | -107,039,000 | -92,439,000 | -79,656,000 | 30,542,000 | 138,423,000 | -53,699,000 | -48,408,000 | -47,590,000 | -50,711,000 | - | - |
Net Income Margin | -41.4% | -0.58 | -0.41 | -0.74 | -0.71 | -0.75 | 0.39 | 0.41 | 0.50 | 0.61 | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 212.6% | 109,031,000 | -96,811,000 | -41,974,000 | -136,800,000 | 5,740,000 | -150,589,000 | -95,221,000 | -118,378,000 | 778,553,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 9.4% | 2,439 | 2,230 | 2,087 | 2,197 | 2,244 | 2,243 | 2,353 | 2,463 | 2,606 | 2,752 | 2,822 | 2,900 | 1,958 | 1,828 | 1,485 | 1,047 | 1,007 | 1,067 | 721 | 494 | 498 |
Current Assets | 11.1% | 2,120 | 1,908 | 1,761 | 1,860 | 1,908 | 1,853 | 1,933 | 2,107 | 2,261 | 2,418 | 2,519 | 2,621 | 1,832 | 1,717 | 1,391 | 966 | 929 | 988 | 664 | 438 | 450 |
Cash Equivalents | 81.6% | 707 | 389 | 528 | 445 | 344 | 212 | 494 | 497 | 684 | 923 | 1,012 | 1,647 | 1,126 | 1,169 | 1,041 | 945 | 890 | 944 | 630 | 428 | 438 |
Net PPE | -3.1% | 147 | 152 | 156 | 159 | 162 | 164 | 166 | 165 | 157 | 138 | 106 | 75.00 | 52.00 | 42.00 | 38.00 | 34.00 | 32.00 | 31.00 | 21.00 | 20.00 | 19.00 |
Liabilities | 2.4% | 355 | 347 | 359 | 381 | 389 | 368 | 399 | 373 | 361 | 352 | 309 | 296 | 152 | 164 | 142 | 136 | 121 | 127 | 129 | 127 | 118 |
Current Liabilities | 9.4% | 119 | 109 | 111 | 133 | 147 | 121 | 151 | 120 | 114 | 120 | 96.00 | 100 | 83.00 | 94.00 | 84.00 | 75.00 | 55.00 | 57.00 | 80.00 | 31.00 | 28.00 |
Shareholder's Equity | 10.7% | 2,084 | 1,883 | 1,728 | 1,816 | 1,855 | 1,875 | 1,954 | 2,091 | 2,245 | 2,399 | 2,513 | 2,604 | 1,805 | 1,664 | 1,343 | 911 | 886 | 939 | 592 | 368 | 380 |
Retained Earnings | -11.7% | -1,116 | -999 | -1,089 | -976 | -899 | -846 | -735 | -560 | -375 | -195 | -54.67 | 72.00 | -686 | -573 | -466 | -374 | -294 | -224 | -255 | -393 | -339 |
Additional Paid-In Capital | 11.2% | 3,199 | 2,878 | 2,821 | 2,799 | 2,761 | 2,735 | 2,709 | 2,670 | 2,635 | 2,598 | 2,566 | 2,530 | 2,490 | 2,236 | 1,808 | 1,283 | 1,179 | 1,162 | 846 | 760 | 718 |
Shares Outstanding | 6.0% | 85.00 | 80.00 | 79.00 | 79.00 | 79.00 | 79.00 | 78.00 | 78.00 | 77.00 | 76.00 | 76.00 | 75.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 4,100 | - | - | - | 4,300 | - | - | - | 11,400 | - | - | - | 4,500 | - | - | - | 2,500 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 214.2% | 109,752 | -96,073 | -39,856 | -133,245 | 8,799 | -113,328 | -105,218 | -141,956 | -135,239 | -86,038 | -81,329 | 807,002 | -100,663 | -81,212 | -75,700 | -29,279 | -52,175 | 3,376 | 133,420 | -36,382 | -43,737 |
Share Based Compensation | 5.3% | 19,405 | 18,420 | 19,968 | 21,765 | 20,875 | 22,805 | 24,545 | 24,852 | 25,745 | 25,768 | 26,199 | 28,331 | 22,092 | 18,930 | 17,240 | 15,697 | 14,151 | 11,857 | 11,343 | 11,186 | 9,671 |
Cashflow From Investing | -20.1% | -97,800 | -81,453 | 121,348 | 216,923 | 117,829 | -175,532 | 87,464 | -56,072 | -114,515 | -8,716 | -565,180 | -293,636 | -167,898 | -204,244 | -330,330 | -3,605 | -2,991 | 7,057 | -2,461 | -2,174 | -1,097 |
Cashflow From Financing | 685.7% | 305,934 | 38,939 | 1,556 | 16,765 | 5,404 | 2,478 | 15,112 | 10,353 | 10,649 | 6,299 | 10,212 | 8,443 | 225,991 | 412,627 | 512,888 | 89,505 | 1,132 | 304,718 | 70,885 | 29,654 | 25,726 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Total revenue | $ 504 | $ 100,000 |
Operating expenses: | ||
Research and development | 76,172 | 99,935 |
General and administrative | 17,953 | 22,360 |
Collaboration expense, net | 46,966 | 42,192 |
Total operating expenses | 141,091 | 164,487 |
Loss from operations | (140,587) | (64,487) |
Other income: | ||
Other income, net | 24,720 | 12,742 |
Total other income, net | 24,720 | 12,742 |
Net loss before income taxes | (115,867) | (51,745) |
Provision for income taxes | (724) | (1,320) |
Net loss | (116,591) | (53,065) |
Foreign currency translation adjustment | (11) | 32 |
Unrealized (loss) gain on marketable securities | (3,454) | 6,227 |
Comprehensive loss | $ (120,056) | $ (46,806) |
Net loss per common share - basic | $ (1.43) | $ (0.67) |
Basic weighted-average common shares outstanding | 81,794,630 | 78,676,986 |
Net loss per common share - diluted | $ (1.43) | $ (0.67) |
Diluted weighted-average common shares outstanding | 81,794,630 | 78,676,986 |
Collaboration Revenue [Member] | ||
Revenue: | ||
Total revenue | $ 0 | $ 100,000 |
Grant Revenue [Member] | ||
Revenue: | ||
Total revenue | $ 504 | $ 0 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 707,427 | $ 389,477 |
Marketable securities | 1,400,698 | 1,304,215 |
Accounts receivable | 0 | 200,000 |
Prepaid expenses and other current assets | 11,499 | 14,386 |
Total current assets | 2,119,624 | 1,908,078 |
Property and equipment, net | 147,253 | 151,945 |
Marketable securities, non-current | 0 | 1,973 |
Intangible assets, net | 2 | 16 |
Restricted cash | 11,516 | 11,591 |
Operating lease assets | 151,254 | 153,993 |
Other non-current assets | 9,368 | 1,975 |
Total assets | 2,439,017 | 2,229,571 |
Current liabilities: | ||
Accounts payable | 16,463 | 38,147 |
Accrued expenses | 76,432 | 45,335 |
Deferred revenue, current | 4,072 | 4,105 |
Accrued tax liabilities | 1,207 | 438 |
Operating lease liabilities | 15,992 | 15,625 |
Other current liabilities | 4,824 | 5,141 |
Total current liabilities | 118,990 | 108,791 |
Deferred revenue, non-current | 13,541 | 14,012 |
Operating lease liabilities, net of current portion | 218,935 | 223,007 |
Other non-current liabilities | 3,615 | 958 |
Total liabilities | 355,081 | 346,768 |
Commitments and contingencies, see Note 7 | ||
Shareholders’ equity: | ||
Common shares, CHF 0.03 nominal value, 130,452,265 and 126,536,183 shares authorized at March 31, 2024 and December 31, 2023, respectively, 85,007,926 and 80,214,694 shares issued at March 31, 2024 and December 31, 2023, respectively, 84,837,610 and 80,044,378 shares outstanding at March 31, 2024 and December 31, 2023, respectively | 2,658 | 2,497 |
Treasury shares, at cost, 170,316 shares at March 31, 2024 and at December 31, 2023 | (62) | (62) |
Additional paid-in capital | 3,199,183 | 2,878,155 |
Accumulated deficit | (1,116,291) | (999,700) |
Accumulated other comprehensive (loss) income | (1,552) | 1,913 |
Total shareholders' equity | 2,083,936 | 1,882,803 |
Total liabilities and shareholders’ equity | $ 2,439,017 | $ 2,229,571 |